0001882749-25-000003.txt : 20251016 0001882749-25-000003.hdr.sgml : 20251016 20251016114505 ACCESSION NUMBER: 0001882749-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251016 DATE AS OF CHANGE: 20251016 EFFECTIVENESS DATE: 20251016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurava Inc. CENTRAL INDEX KEY: 0001882749 ORGANIZATION NAME: EIN: 842192771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561059 FILM NUMBER: 251396899 BUSINESS ADDRESS: STREET 1: 101 W DICKMAN STREET STREET 2: SUITE 807 CITY: BALTIMORE STATE: MD ZIP: 21230 BUSINESS PHONE: 281-995-8055 MAIL ADDRESS: STREET 1: 101 W DICKMAN STREET STREET 2: SUITE 807 CITY: BALTIMORE STATE: MD ZIP: 21230 FORMER COMPANY: FORMER CONFORMED NAME: Neurava LLC DATE OF NAME CHANGE: 20210913 D 1 primary_doc.xml X0708 D LIVE 0001882749 Neurava Inc. 101 W DICKMAN STREET SUITE 807 BALTIMORE MD MARYLAND 21230 281-995-8055 DELAWARE Neurava LLC Corporation true 2022 Jay Shah 101 W Dickman Street, Suite 807 Baltimore MD MARYLAND 21230 Executive Officer Director Promoter Vivek Ganesh 101 W Dickman Street, Suite 807 Baltimore MD MARYLAND 21230 Executive Officer Director Promoter Mona Chadha 101 W Dickman Street, Suite 807 Baltimore MD MARYLAND 21230 Director John Kay 101 W Dickman Street, Suite 807 Baltimore MD MARYLAND 21230 Director Daniel Moore 101 W Dickman Street, Suite 807 Baltimore MD MARYLAND 21230 Director Other Technology Decline to Disclose 06b false 2025-10-15 false true false 0 7000000 1600000 5400000 false 2 0 0 0 true Proceeds will be used for general corporate purposes. The above amount excludes salary and bonus compensation which may be made to officers, directors, employees, and consultants of the Issuer. false Neurava Inc. Jay Shah Jay Shah Co-CEO 2025-10-16